記住我
Alzheimer’s clinical syndrome
CAAcerebral amyloid angiopathy
DMTdisease modifying therapy
FTLDfrontotemporal lobar degeneration
GMMGaussian mixture models
iNPHidiopathic normal pressure hydrocephalus
J-ADNIJapanese Alzheimer’s Disease Neuroimaging Initiative
MCImild cognitive impairment
MSAmultiple system atrophy
NfLneurofilament light chain
PPAprimary progressive aphasia
PETpositron emission tomography
PSPprogressive supranuclear palsy
VCIvascular cognitive impairment
KeywordsCerebrospinal fluid (CSF)
Biomarker
AT(N) classification
Alzheimer’s clinical syndrome
Aβ42/Aβ40 ratio
Neurofilament light (NfL)
Availability of data and materialsThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
© 2023 The Author(s). Published by Elsevier Inc.
留言 (0)